HealthSonix Develops New Treatment Protocols for Dupuytren’s Contracture; Patients Show Positive Results

IRVINE, CA -- (MARKET WIRE) -- May 15, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it has achieved successful results in the treatment of patients with Dupuytren’s Contracture using its sound pulse technology.